HPV Vaccination

Paper Summary:

This study considers the issue of preventing the quadrivalent human papilloma virus (HPV) through a immunization program of girls in a California school. The population of the study is specifically Latino, and issues surrounding health care in the Latino community are discussed. The efficacy of the vaccination is described as are the methods in which this disease is transferred. The paper also explains the dangers of HPV, giving statistics of the consequences of infection. Methods of prevention, including vaccination, are also highlighted. The paper concludes that further research which include studies to determine the long term efficacy of the vaccination as well as the length of protection it offers is necessary.

Outline
Abstract
Background/Review of Literature
Discussion/Recommendations for Further Study

From the Paper:

"According to the Centers for Disease Control, Advisory Committee on Immunization and Practices, Resolution 6/06-2 the administration of the quadrivalent Human Papilloma Virus vaccination is suggested for administration to girls as young as 9 but preferably in the age set of 11-12, and as a catch up vaccination for girls aged 13-18. The vaccination is to be given in three staggered doses with the second dose given 2 months from the first and the third 6 months after the first dose. This is based on the positive research findings of both non-profit research groups and pharmaceutical companies developing preventative HPV vaccinations. This work addresses the validity of mandating this vaccine in Solano County California, upon these age guidelines as a prophylactic measure to decrease the incidence of the specific HPV types (6,11,16,18) associated with the vaccination, namely the Merck vaccination trade name Gardasil. In addition to this informative resolution the California Department of Health Services has obtained the vaccination and has made compatible resolutions to vaccinate girls according to the national recommendations, either through private physicians or through state and local agency immunization programs, (California Vaccines for Children (VFC) Program Providers) such as those found in Solano County."

Sample of Sources Used:

• Halfon, N., Ebener, P. A., Sastry, N., Ahn, P., Cherman, L., Hernandez, J., et al. (2000). California Health Report. Santa Monica, CA: Rand. Hold Back Knee-Jerk Reactions on HPV Vaccine. (2007, January 12). The Washington Times, p. B02. HPV Vaccines: What You Need to Know. (2006, November 27). Daily Herald (Arlington Heights, IL), p. 4.
• Lowy D.R. & Schiller J.T. (2006) "Prophylactic human papillomavirus vaccines" Journal of Clinical Investment. 116:1167-1173 at: http://www.jci.org/cgi/content/full/116/5/1167.
• Officials Question HPV Program. (2003, August 25). The Washington Times, p. A06.
• Saslow D, Castle PE, Cox JT, et al. (2007) "American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin;57:7-28 online at: http://caonline.amcancersoc.org/cgi/content/abstract/57/1/7?ijkey=5f9f1543965172296d3b60ebae47720df3f733d6&keytype2=tf_ipsecsha
• Sex-Disease Shot Urged for Girls; Cervical Cancer Linked to HPV. (2007, January 5). The Washington Times, p. A03.

More papers on HPV Vaccination:

• Analytical Essay # 123524 : "Political Process of HPV Vaccine"
• Term Paper # 135838 : "HPV and Pseudoscience"
• Term Paper # 105223 : "The Human Papilloma Virus"

APA Citation:

MLA Citation: